Company: LGN
Filing Date: 2025-12-09
Form Type: S-1
Source: 0001193125-25-312729
Chunk: 234

Company: Legence Corp.
Filing Date: 2025-12-09
Form: S-1
Chunk 234
---
 whole or in part. In connection with this offering, Goldman Sachs & Co. LLC and Jefferies LLC have agreed to release, with respect to this offering, certain of the lock-up restrictions agreed to by each of the Company and the selling stockholders with respect to up to 8,050,000 shares of our Class A Common Stock (including the 1,050,000 additional shares of Class A Common Stock pursuant to the underwriters’ option to purchase additional shares) in this offering that are held by the selling stockholders, provided that the release of shares of the Company’s Class A Common Stock held by the selling stockholders is limited to the shares actually sold in this offering. The Company is not selling any shares of Class A Common Stock in this offering, and will not receive any of the proceeds from the shares of Class A Common Stock sold by the selling stockholders. In connection with the IPO, the Company and its executive officers, directors, and holders of substantially all of the Company’s outstanding Common Stock immediately prior to the IPO agreed with the underwriters, 159

subject to certain exceptions, not to dispose of or hedge any of their shares of Class A Common Stock or securities convertible into or exchangeable for shares of Class A Common Stock during the period from the date of this prospectus continuing through the date 180 days after the date of the final prospectus relating to the IPO (the “Restricted Period”), except with the prior written consent of the representatives. Any executive officers and directors that were appointed subsequent to our IPO have agreed with the underwriters, in connection with this offering, to a Restricted Period on the same terms from the date of this prospectus continuing through the date 90 days after the date of the final prospectus relating to this offering. The restrictions described in the paragraph above relating to the Company do not apply to, among other things:

| • |     | the sale of shares to be sold pursuant to the underwriting agreement for this offering; |

| • |     | transfers of Common Stock or any security convertible into Common Stock in connection with the exercise of                                                                                                                                               
 options or warrants or the vesting, exercise or settlement of any other equity or equity-based award, in each case, granted pursuant to the Company’s or Legence Holdings’ equity or long-term incentive plans or otherwise outstanding on               
 the date of this prospectus and disclosed herein, including any Common Stock withheld by the Company or any of its applicable affiliates to pay any applicable exercise price or tax withholding associated with such awards; provided